脐带间充质干细胞治疗难治性原发性血小板减少性紫癜近期疗效  被引量:4

Latter efficacy evaluation on the treatment of refractory idiopathic thrombocytopenic purpura with human umbilical cord mesenchymal stem cells

在线阅读下载全文

作  者:徐淑芬[1] 白海[1] 王存邦[1] 潘耀柱[1] 陈燕[1] 周树娥[1] 

机构地区:[1]甘肃省兰州市兰州军区兰州总医院血液科,甘肃兰州730050

出  处:《中国现代医学杂志》2014年第33期35-38,共4页China Journal of Modern Medicine

摘  要:目的观察人脐带间充质干细胞(h UC-MSCs)治疗难治性原发性血小板减少性紫癜(ITP)近期疗效及不良反应。方法分析12例2012年1月-2012年12月该院住院确诊为难治性ITP患者的临床资料,所有患者均给予人脐带间充质干细胞输注治疗,每次静脉输注(3~5)×10^7个细胞,1次为1个疗程,每周1次,共2~3疗程。结果本组患者的起效时间为1~4周,12例患者中4例获完全缓解(CR),CR率为33.3%,4例获部分缓解(PR),PR率为33.3%,总有效率(CR+PR)为66.6%(8/12),2例血小板抗体正常患者及2例脾切除患者无效。T细胞亚群的异常表达可能参与了ITP的免疫发病机制,h UC-MSCs输注对T细胞亚群有调节作用,血小板相关抗体及巨核细胞数与疗效有一定相关性。结论人脐带间充质干细胞治疗难治性ITP近期疗效好,副作用轻微,可在临床推广使用。[ Objective ] To observe the clinical effect and side effects of human umbilical cord mesenchymal stem cells (hUC-.MSCs) in the treatment of refractory idiopathic thrombocytopenic purpura (ITP). [ Methods ] The clinical data of 12 patients with refractory ITP who were followed up in our hospital from January 2012 to December 2012 were analyzed. A total of 12 patients were given hUC-MSCs by intravenous injection at a dose of (3-5)×10^7 cell in a course, 2-3 cycles. [ Results ] The majority of responses took place in the 1-4 week, 4 complete response (CR) and 4 partial response (PR) were observed, the total response rate (CR+PR) was 66.6% (8/12) after treatment with hUC- MSCs, two normal platelet associated IgG (PAIgG) and two splenectomized patients had no response. The abnormal expression of T cell subsets may involve in ITP immunopatbogenesis, the hUC-MSCs intravenous injection has mod- ulatory effects on T cell subsets in case with ITP, there was a close relationship and certain correlation among the levels of PAIgG and the count of megakaryocyte. [ Conclusions ] Our results show that the hUC-MSCs intravenous injection induces a clinically significant response in patients with refractory ITP, it induced rapid response, with lit- tle associated toxicity, but it have a relapse tendency, hUC-MSCs should be applied to the refractory ITP treatment.

关 键 词:人脐带间充质干细胞 原发性血小板减少性紫癜 治疗效果 

分 类 号:R329.2[医药卫生—人体解剖和组织胚胎学] R55[医药卫生—基础医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象